Member Info for oilmagnet477

You also have to factor in the other products in the pipeline.
The Adapt Oxygen Concentrator is scheduled for a Q4 2020 launch - you'd have to imagine that the Company will be going nuts - not only to get the XPLO2R machine into mass production but to advance the new model as well. With FDA removing red tape, you'd be mad not to take advantage.

https://belluscura2.wpengine.com/product-pipeline/

https://apps.who.int/trialsearch/Trial2.aspx?TrialID=NCT04299178

https://www.bioportfolio.com/resources/trial/266420/Usability-Evaluation-of-a-Portable-Oxygen-Concentrator.html

Things are moving on.....

submission to fda is mentioned by TEK CEO in an RNS dated 10th Feb:

Clifford M. Gross Ph.D., Executive Chairman of Tekcapital plc commented:
"We are pleased to see the additional progress of Belluscura as it continues to strengthen its intellectual property in the oxygen therapy space to help patients afflicted with acute respiratory distress caused by the Coronavirus. Additionally, we anticipate that Belluscura is likely to receive FDA clearance for their portable oxygen concentrator within the next 90 days. "

Not exactly sure when Belluscuras submitted it but it is reportedly being fast tracked and now, since Trump's statement re FDA relaxation, it could land asap

I remember back in the long distant past, DR holding a conference call and answering questions which had been posted in the online chat facility.

Russell really needs to get with the programme. Covid-19 aint going to be over by 30th March - we will more than likely be in lock down. Come on!

Bring your own camp chair and flask of coffee....
One way to cut overhead.....

"Shareholders intending to attend the Adjourned Meeting should note that, should the Company's office at Coveham House not be available for any reason, the meeting will be held externally, and they should dress accordingly."

Does this seriously mean the AGM will be held in the Car Park so wrap up warm!!???

Our investment objective is significant growth of Net Assets resulting from the commercialisation of compelling IP
In 2018 Net Assets grew 51% to US $16.1m (2017: US $10.7m)
Growth continued in H1 2019 with Net Assets at US $20.5m
2019 H1 NAV per share US $0.38
2018 NAV per share US $0.30
2017 NAV per share US $0.25
2016 NAV per share US $0.09
Total Revenue 2019 H1; US $5.4m (2018 H1: US $1.3m)
Revenue from services 2019 H1; US $614,394 (2018 H1: US $639,561)
Operating expenses 2019 H1 were reduced 7% to US $740,947 (2018 H1: US $800,643)
2019 H1 profit before tax: US $4.4m (2018 H1: US $105,996)
Continued development of four high-value portfolio companies:
Belluscura, Lucyd, Salarius & Guident with exciting near-term potential catalysts

people seem to be forgetting (ignoring potential news flow) that this company generates more revenue than its' current MC and makes a profit. How many AIM companies can claim that?

Also been buying open mkt to increase to 9.66%

Cheap shares being hoovered up

sort your s***e out and get trade and price reporting fixed. It is not good enough

Lord Willetts is a NED of this Company.

Never what you know but who you know................

So currently sat at below 2016 valuation...........
Current H1 revenue from a year ago is more than our current MC...

????????????

Our investment objective is significant growth of Net Assets resulting from the commercialisation of compelling IP
In 2018 Net Assets grew 51% to US $16.1m (2017: US $10.7m)
Growth continued in H1 2019 with Net Assets at US $20.5m
2019 H1 NAV per share US $0.38
2018 NAV per share US $0.30
2017 NAV per share US $0.25
2016 NAV per share US $0.09
Total Revenue 2019 H1; US $5.4m (2018 H1: US $1.3m)
Revenue from services 2019 H1; US $614,394 (2018 H1: US $639,561)
Operating expenses 2019 H1 were reduced 7% to US $740,947 (2018 H1: US $800,643)
2019 H1 profit before tax: US $4.4m (2018 H1: US $105,996)
Continued development of four high-value portfolio companies:
Belluscura, Lucyd, Salarius & Guident with exciting near-term potential catalysts

https://belluscura2.wpengine.com/product-pipeline/

TEK own 18.9% of Belluscura so undoubtedly today is a boost but they also own 3 other elements, 2 outright and another,
Salarius 91.7%. Good listen here: https://www.youtube.com/watch?v=A5LfKYjAR2A&feature=youtu.be

not just for KRS, but for many AIM shares, if the licence and production do land soonish, the winners will be those that have just come on board (and not gone through years of disappointment) or those with the wherewithall and confidence to significantly average down.

Hardly a great example for years of dedicated support from LTH, without whom this company would have gone ***z up years ago

I stopped myself mentioning the shovel related implement..........

Not sure mentioning Gnassingbe is overly helpful. We were spun endless bull about how him winning the election in 2015 would bring stability. 2x results on and the end result - zilch nada etc etc even though KRS have had to sell out 10 % to get a licence that was already a given (following on from the exploration permit as far back as 2014) and guarantee jobs for the local economy and STILL no licence.

Don't get me wrong - I HATE derampers and as many will bear witness I've had run ins with many on here over the years but you really have to wonder at it now - had I listened to one or 2 of them back in the day, I'd have a shed load more cash left now.

I'd be the happiest bloke on the planet if this still comes good but as Jim states, many LTHs here probably need 0.75 to get a profit - after 6 yrs, that's a crap return.

sorry - was referring to Wozniak and Barrowman.
8.2m buy was just indicative :-)

8.2m shares
Big money knows where this is going